We are extremely proud to see this important work published in Gastroenterology.

This study represents a key step forward in understanding the mechanisms of action of our lead candidate EXL01 (Faecalibacterium prausnitzii), highlighting its anti-inflammatory effects and its role in the rewiring of energy metabolism in human monocytes.

Congratulations to Nathalie Rolhion, Harry Sokol, Camille Danne, and the entire author team for this outstanding collaborative effort, bridging microbiology, immunology, and metabolism.

We now look forward to the results of the ongoing clinical trials with F. prausnitzii EXL01, which will further explore its therapeutic potential.

Open-access paper: https://lnkd.in/guhY55aF

‍